High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection
Autor: | Simonetta, Federico, Hua, Stéphane, Lecuroux, Camille, Gérard, Sandie, Boufassa, Faroudy, Saez-Cirion, Asier, Pancino, Gianfranco, Goujard, Cécile, Lambotte, Olivier, Venet, Alain, Bourgeois, Christine |
---|---|
Přispěvatelé: | Guibert, Marie-Genevieve, INSERM U1012, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Hôpital Universitaire de Genève = University Hospitals of Geneva (HUG), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Régulation des Infections Rétrovirales, Institut Pasteur [Paris] (IP), Service de médecine interne, immunologie clinique [Béclère], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), This work was supported by the Agence Nationale de la recherche contre le SIDA et les hépatites virales (ANRS) and Fondation de France. Federico Simonetta was also supported by the Fondation pour la recherche médicale (FRM)., Hôpital Universitaire de Genève, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Pasteur [Paris] |
Rok vydání: | 2014 |
Předmět: |
ddc:616
Adult [SDV.IMM] Life Sciences [q-bio]/Immunology Cellular Response to Infection HIV Infections CD8-Positive T-Lymphocytes Middle Aged HIV Infections/immunology/virology CD57 Antigens T-Box Domain Proteins/metabolism CD8-Positive T-Lymphocytes/virology [SDV.IMM]Life Sciences [q-bio]/Immunology Humans Antigens T-Box Domain Proteins CD57 Antigens CD57/immunology |
Zdroj: | Journal of Virology, Vol. 88, No 20 (2014) pp. 11861-11871 Journal of Virology Journal of Virology, 2014, 88 (20), pp.11861--11871. ⟨10.1128/JVI.02013-14⟩ Journal of Virology, American Society for Microbiology, 2014, 88 (20), pp.11861--11871. ⟨10.1128/JVI.02013-14⟩ |
ISSN: | 1098-5514 0022-538X |
DOI: | 10.1128/JVI.02013-14⟩ |
Popis: | International audience; During HIV infection, increased CD57 expression among CD8(+) T cells has been associated with immune senescence and defective immune responses. Interestingly, CD57-expressing CD8(+) T cells exhibit a dual profile, being simultaneously highly cytotoxic (terminally differentiated effectors) and poorly proliferative (replicative senescent). Recent publications point toward a positive role of CD57-expressing CD8(+) T cell subsets, presumably due to their high cytolytic activity. We further investigated the phenotype of CD57-expressing CD8(+) T cells in healthy donors and during HIV infection combining CD57 expression to Eomesodermin (EOMES), a T box transcription factor which determines, coordinately with T-bet, effector and memory CD8(+) T cell differentiation. We defined in healthy donors two functionally distinct CD57-expressing CD8(+) T cell subsets exhibiting different levels of EOMES expression: EOMES(hi) CD57(+) and EOMES(int) CD57(+) CD8(+) T cells. EOMES(hi) CD57(+) cells exhibited low cytotoxic activity but preserved proliferative capacity and interleukin 7 (IL-7) receptor expression, whereas EOMES(int) CD57(+) cells exhibited obvious cytotoxic functions and a more terminally differentiated phenotype. We next performed a similar analysis in different contexts of HIV infection: primary infected patients, long-term viremic patients, aviremic patients treated with antiretroviral therapy, and HIV controllers; we demonstrated a higher percentage of CD57-expressing cells in all HIV-infected patients regardless of virological status. When heterogeneity in EOMES expression among CD57 cells was taken into account, we detected significantly higher proportions of EOMES(hi) CD57(+) cells among HIV-specific and nonspecific CD8(+) T cells from HIV controllers than in aviremic antiretroviral-treated patients and viremic patients. Importantly, such a peculiar non-terminally differentiated EOMES(hi) CD57(+) phenotypic profile was associated with viral control. Importance: This study demonstrates that functional heterogeneity exists among CD57-expressing CD8 T cells, which include both terminally differentiated, highly cytotoxic EOMES(int) CD57(+) CD8(+) T cells and less differentiated EOMES(hi) CD57(+) CD8 T cells, which do not exhibit immediate cytotoxic functions but present high proliferative capacity. Interestingly, HIV controllers present a high proportion of EOMES(hi) CD57 cells among CD57-expressing HIV-specific CD8 T cells compared to both long-term viremic and aviremic antiretroviral therapy (ART)-treated patients, suggesting a beneficial role for this cell subset in viral control. |
Databáze: | OpenAIRE |
Externí odkaz: |